Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biovica International AB (publ)
  6. News
  7. Press Releases
    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ BIOVICA INTERNATIONAL AB (PUBL)
10/12BIOVICA INTERNATIONA : Biovica International
AQ
10/12BIOVICA INTERNATIONAL : Announcement from Biovica International's extra general meeting
AQ
09/23BIOVICA INTERNATIONAL : Notice of extra general meeting in Biovica International AB
AQ
09/15BIOVICA INTERNATIONAL : DiviTum«TKa results from SWOG study published in Clinical Cancer R..
AQ
09/14BIOVICA INTERNATIONAL : Promising DiviTumTKa results from BioItaLEE study presented at ESM..
AQ
09/13BIOVICA INTERNATIONA : Biovica International
AQ
09/13BIOVICA INTERNATIONAL : provides update on FDA application process
AQ
08/31BIOVICA INTERNATIONAL : Announcement from Biovica International's annual general meeting
AQ
08/31BIOVICA INTERNATIONAL : DiviTum«TKa approaching FDA approval
AQ
08/27BIOVICA INTERNATIONAL : CEO's presentation ahead of the 2021 Annual General Meeting has be..
AQ
08/10BIOVICA INTERNATIONAL : strengthens management team
AQ
07/30BIOVICA INTERNATIONAL : Notice of annual general meeting in Biovica International AB
AQ
06/30BIOVICA INTERNATIONAL AB : – Annual report for the financial year 2020/2021 publishe..
AQ
06/17BIOVICA INTERNATIONAL : Year-end Report February-April 2020/2021
AQ
06/11BIOVICA INTERNATIONAL : - Premium potential
AQ
05/22BIOVICA INTERNATIONAL : Capital Markets Day invitation June 9
AQ
05/20BIOVICA INTERNATIONAL : DiviTumTKa shows strong capabilities in malignant melanoma
AQ
04/29BIOVICA INTERNATIONAL : strengthens the management team
AQ
04/23BIOVICA INTERNATIONAL : DiviTum«TKa budget impact model results show potential for savings..
AQ
03/18BIOVICA INTERNATIONAL : Q3 Interim report November-January 2020/2021
AQ
03/11BIOVICA INTERNATIONAL : DiviTumTKa prognostic for long-term outcome
AQ
02/26BIOVICA INTERNATIONAL : Nomination Committee for Biovica for the 2021 Annual General Meeti..
AQ
01/29BIOVICA INTERNATIONAL : FDA resumes review of DiviTum«TKa submission
AQ
01/18BIOVICA INTERNATIONAL : DiviTum«TKa in early treatment resistance trial
AQ
01/16BIOVICA INTERNATIONAL : FDA resource reallocation continues to impact DiviTum«TKa timeline
AQ
01/12BIOVICA INTERNATIONAL : CEO and main shareholder lends shares for redemption of option pro..
AQ
2020BIOVICA INTERNATIONAL : Q2 Interim Report August-October 2020/2021
AQ
2020BIOVICA INTERNATIONAL : DiviTum«TKa included in new UK breast cancer study
AQ
2020BIOVICA INTERNATIONAL : Multicenter study PYTHIA presents positive DiviTum«TKa results
AQ
2020BIOVICA INTERNATIONAL : CDK 4/6 dosing study supports DiviTum«TKa as an early and effectiv..
AQ
2020BIOVICA INTERNATIONAL : announces initial results in clinical genomics study of DiviTum«TK..
AQ
2020BIOVICA INTERNATIONAL : DiviTum«TKa Monitoring Capabilities Confirmed in SWOG Study
AQ
2020BIOVICA INTERNATIONAL : FDA submission will proceed to substantive review
AQ
2020BIOVICA INTERNATIONAL : FDA resource reallocation impacts DiviTum«TKa timeline
AQ
2020BIOVICA INTERNATIONAL : DiviTum«TKa in four posters at SABCS
AQ
2020BIOVICA INTERNATIONAL : completes 510(k) submission for DiviTum«TKa to the FDA
AQ
2020BIOVICA INTERNATIONAL : Bulletin from the annual general meeting in Biovica
AQ
2020BIOVICA Q1 INTERIM REPORT : May-July 2020/2021
AQ
2020BIOVICA INTERNATIONAL : carries out a directed share issue of Class B shares and raises pr..
AQ
2020BIOVICA INTERNATIONAL : intends to carry out a directed share issue of Class B shares
AQ
2020BIOVICA INTERNATIONAL : successfully completes clinical validation for DiviTum« TKa FDA su..
AQ
2020BIOVICA INTERNATIONAL PUBL : Notice to AGM for Biovica International AB
AQ
2020BIOVICA INTERNATIONAL AB : – Annual Report for the fiscal year 2019/2020 published
AQ
2020BIOVICA INTERNATIONAL PUBL : completes analytical validation as part of FDA application
AQ
2020Biovica Year-end Report for 2019/2020
AQ
2020BIOVICA INTERNATIONAL PUBL : DiviTum« acknowledged in ASCO educational book
AQ
2020BIOVICA INTERNATIONAL PUBL : DiviTum« and TK activity acknowledged in highly renowned scie..
AQ
2020BIOVICA INTERNATIONAL PUBL : provides market share target at today's Capital Market Day
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020BIOVICA INTERNATIONAL PUBL : invites to virtual Capital Markets Day 11 May
AQ
2020BIOVICA INTERNATIONAL PUBL : initiates a collaboration with Mayo Clinic to study DiviTum f..
AQ
2020BIOVICA INTERNATIONAL PUBL : strengthens its commercial leadership
AQ
2020BIOVICA INTERNATIONAL PUBL : DiviTumá-áfirst study published on CDK4/6 inhibitor against c..
AQ
2020BIOVICA INTERNATIONAL PUBL : provides updates on FDA application
AQ
2020BIOVICA INTERNATIONAL PUBL : Clinical Cancer Research publishes results supporting DiviTum..
AQ
2019BIOVICA INTERNATIONAL PUBL : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT : áWork with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metastatic breast..
PU
2019BIOVICA INTERNATIONAL PUBL : DiviTum - Strong prognostic marker in operable breast cancer
AQ
2019BIOVICA INTERNATIONAL PUBL : DiviTum validated as a dynamic biomarker in metastatic breast..
AQ
Upcoming event on BIOVICA INTERNATIONAL AB (PUBL)